Quote:The Real Meaning of All Those Right-Wing Conspiracy Theories About Hillary’s Health
The lunatic right is desperate for a deus ex machina.
And why not? Divine intervention requires no change of strategy for Trump, and no 'heavy lifting' by his campaign to get out the vote rather than waste time on legally questionable 'poll monitoring'.
Lazy, undisciplined and stupid is no way to run a campaign, son. LOL!
By Michelle Goldberg
If you spend much time on right-wing media, you might have heard that Hillary Clinton suffers from seizures, dementia, Parkinson’s disease, and possibly even tongue cancer. As David Weigel writes in the Washington Post, Sean Hannity has spent all week dredging up debunked rumors about Clinton’s health, giving special attention to a photo of her stumbling as she climbs a set of outdoor stairs while wearing heels in February. Donald Trump nodded to the rumors at a rally last weekend, saying, “Honestly I don’t think she’s all there.”
Photos of “leaked” medical records describing Clinton’s “subcortical vascular dementia” and “complex partial seizures” are circulating online; as Snopes points out, they are printed on plain paper rather than letterhead, and they misstate the professional title of Clinton’s physician, Lisa Bardack.
(An actual letter from Bardack says Clinton is in “excellent physical condition and fit to serve as President of the United States.”)
The idea that Hillary Clinton is secretly much weaker than she appears is pure wishful thinking.
As Clinton conspiracies go, this stuff is picayune. After all, some of the same right-wing characters painting Clinton as a frail invalid are also accusing her of masterminding the murder of Democratic National Committee staffer Seth Rich, who is said, without evidence, to be involved in last month’s leak of DNC documents.
(This is only the latest of the dozens of murders some attribute to the Clintons.)
Echoing the right-wing conspiracy site InfoWars, Trump has accused Clinton of co-founding ISIS, though very early Friday morning, he expressed incredulity on Twitter that the media took his claim seriously: “THEY DON’T GET SARCASM?” Clinton has been accused of maintaining a secret police force to harass her critics.
Countless Republicans have said she deliberately covered up the motives for the terrorist attack in Benghazi, Libya. Indeed, though right-wingers now cite her 2012 concussion as evidence of her failing health, Fox News previously accused her of faking the concussion to get out of testifying about Benghazi.
It’s hard to blame conspiracy theorists for this contradiction; with so many rumors swirling around, internal consistency is impossible.
What’s striking about the rumors of Clinton’s imminent collapse aren’t the stories themselves, but the purpose they serve. Most Clinton conspiracy theories are meant to delegitimize her, to explain away her baffling, irksome persistence in public life as a product of a scarcely comprehensible homicidal ruthlessness. The idea that she’s secretly much weaker than she appears, by contrast, is pure wishful thinking.
It’s the demented cousin of the right-wing conviction, in the run up to the 2012 election, that polls showing Mitt Romney losing were skewed. “Hillary Clinton’s Health in Rapid Decline—Will She Even Make It to Election Day at This Rate?” asks a headline on InfoWars.
This is the speculation of desperate men hoping for a deus ex machina to save them from a Clinton presidency.
That means that on some level, these men are starting to understand that this future is bearing down on them. If they’re living out the Kübler-Ross stages of grief, this is denial. One can only imagine what the next phase is going to look like: anger,
The Real Meaning of All Those Right-Wing Conspiracy
Top 10 Most Recent News Articles
Spencer Spirit Completes Hot Topic Acquisition
Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...
Continue Reading
COFE Tech's $178M Pre-IPO Boost: Bold Move in MENA
COFE Tech's Pre-IPO Raise: Scoring Big Dollars Today I'm reading this deal 'bout COFE Tech, and let me tell ya, there's more to chew over than a bowl of oatmeal. They just wrapped up a pre-IPO round at a hefty $178 million valuation. This wasn't just any ol' investment — we're talking about Wa'ed Ventures, the venture arm of Aramco, along with some heavy-hitter partners...
Continue Reading
Ace Hardware Hits 100th Store Milestone, Talks Growth
Ace Hardware Signals Expansion Through 100th Store Anyone eying the hardware retail landscape knows that Ace Hardware is not just coasting through another predictable quarter. No, this coop, fondly dubbed the helpful hardware folks, has just cranked open the doors on its 100th new store of 2026. Yep, they're charging full-throttle on their expansion strategy, determined...
Continue Reading
Demand for Home Care Workers Soars: 850k by 2035
A Looming Need for Home-based Care Take a long, deep breath and visualize this: by 2035, America's gonna need roughly 850,000 more home care workers. That's a head-spinning figure, and if you haven't been keeping up with the projections, let me fill you in on something the Bureau of Labor Statistics threw our way. They're saying home health and personal care aides will...
Continue Reading
ePlus Wins Big: First Ambassador Partner for Everpure
ePlus Breaks Ground with Everpure There's a new chapter unfolding in the tech sector, and ePlus has carved its name on the marquee. Achieving the exclusive Ambassador Partner Status with Everpure, ePlus becomes the first in North America to hit this high note. In the crowded room of tech partnerships, this isn't just a pat on the back—it's a gold star that screams...
Continue Reading
Dr. Anastasatos to Speak on Endoscopic Brow Lift in Crete
Conference Spotlight: Endoscopic Brow Lift Plastic surgeons from across the globe are gathering in Crete, Greece, for a conference that promises to shake up the aesthetic world. Among the big names is Dr. John M. Anastasatos, who'll be lifting more than just eyebrows with his presentation on the endoscopic brow lift. This isn't just another facelift spiel—no sir—this...
Continue Reading
Power Solutions Litigations Prompt Investor Caution
A Storm Brews Over Power Solutions International Look, if you're holding Power Solutions International (NASDAQ:PSIX) in your portfolio, it's time to perk up. The air's thick with talk that Kuehn Law, the firm with a head for shareholder litigation, is on their case. They're poking around, seeing if some executives got a little too creative with the truth. Word on the...
Continue Reading
Lindian's Bold Leap into Rare Earths Processing
Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...
Continue Reading
Moore and RMI Forge Alliance for Data-Driven Success
RMI and Moore Team Up for Strategic Evolution Let me tell ya, RMI Direct Marketing deciding to join forces with Moore’s AudienceFirst Media is a decision that’ll ripple through the data-driven waters for quite some time. They ain’t merging, mind you, but they’re definitely tying their ships together with a shared compass set on list management and brokerage...
Continue Reading
Potassium Fluoride Market Growth Sparks Interest
Here's a story you might not have expected—potassium fluoride is finding its spotlight! With the market projected to tick upwards from USD 0.43 billion in 2026 to USD 0.51 billion by 2032, there's more here than meets the eye. A steady CAGR of 2.9% might not scream excitement, but steady growth often does the trick in chemicals. Why the Buzz Around Potassium Fluoride?...
Continue ReadingTop 5 Most Recently Viewed Articles
Skywork Revolutionizes Music Creation with Mureka V7 Launch
Skywork Launches Mureka V7: A New Era in Music Production Skywork has officially unveiled its latest model, the Mureka V7, along with an innovative tech addition, the Mureka TTS V1. These groundbreaking models promise to reshape experiences for music creators and enthusiasts alike. Mureka V7: Crafting Exceptional Melodies The Mureka V7 is not just another update; it’s a...
Continue Reading
BOK Financial Prepares for Earnings Report Amid Investor Optimism
BOK Financial Earnings Report Insights BOK Financial (NASDAQ: BOKF) is gearing up to release its latest quarterly earnings report soon, and investors are eager to gain insight into the company’s financial health. Anticipation is building, with analysts projecting an earnings per share (EPS) of $1.98. This forthcoming report holds significant interest for those invested...
Continue Reading
Ashley McEvoy's $1.03M Buy: A Bullish Signal for PODD
Major Insider Purchase Lights a Fire Well, folks, let’s talk about Ashley McEvoy, the President and CEO over at Insulet (NASDAQ:PODD). She just dropped a cool $1.03 million on 4,300 shares of her own company. That’s no chump change—this ain't a casual lunch treat. This insider buy, filed with the SEC on February 23, shines a bright spotlight on her confidence in the...
Continue Reading
ClassOne Technology's Solstice S8 Empowers AOI's AI Growth
ClassOne Technology Partners with Applied Optoelectronics ClassOne Technology, an innovative provider of electroplating and processing tools for microelectronics manufacturing, is set to enhance Applied Optoelectronics Inc.'s (NASDAQ: AAOI) capabilities. The partnership revolves around the Solstice S8 system, specifically designed to meet the swelling demands of...
Continue Reading
Ascendis Pharma Faces Stock Decline Due to Revenue Guidance
Stock Performance of Ascendis Pharma Recently, Ascendis Pharma (NASDAQ: ASND) saw a decline in its stock price by 1%. This drop followed the company’s latest revenue forecast for Skytrofa, its treatment designed for growth hormone deficiency. The announcement came during the influential 43rd Annual JPMorgan Healthcare Conference, where CEO Jan Mikkelsen laid out the...
Continue Reading